Application‑focused Melanin segmentation isolates three dominant end‑uses: cosmetics, pharmaceuticals, and research. The cosmetics segment, encompassing skin‑care pigments, makeup, and UV‑filter additives, represents the largest share (≈55 %) driven by consumer demand for natural‑looking coloration and photoprotective benefits; product formulations increasingly integrate melanin to replace synthetic dyes and improve skin‑compatibility. The pharmaceutical segment, which includes drug‑delivery carriers, photoprotective agents, and imaging contrast enhancers, contributes roughly 30 % of market revenue; its growth is underpinned by melanin’s biocompatibility, radical‑scavenging capacity, and ability to modulate drug release kinetics. The research segment, covering biomedical diagnostics, bio‑electronics, and material‑science investigations, accounts for the remaining 15 %; academic and corporate R&D spend on melanin‑based sensors and conductive inks fuels this niche but high‑margin area. Together, these application categories delineate the demand side of the Melanin market, informing investment priorities and guiding product‑development pipelines.